A study for elimination of HCV among hemodialysis patients with novel delivery model in Taiwan
Latest Information Update: 16 Oct 2020
At a glance
- Drugs Elbasvir/grazoprevir (Primary) ; Glecaprevir/pibrentasvir (Primary) ; Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 16 Oct 2020 New trial record
- 29 Aug 2020 Results presented at The International Liver Congress 2020